Literature DB >> 71446

Prostaglandins and breast cancer.

A Bennett, E M Charlier, A M McDonald, J S Simpson, I F Stamford, T Zebro.   

Abstract

Malignant human breast tumours produced more prostaglandin-like material during homogenisation than did benign tumours or normal breast tissue. Greatest synthesis in vitro occurred with tumours associated with bone metastases, and the highest "basal" amounts tended to occur in tumours showing spread histologically. It is suggested that prostaglandins may play a part in tumour spread and growth in bone and that drugs which inhibit prostaglandin synthesis may be valuable therapeutic agents in cancer.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71446     DOI: 10.1016/s0140-6736(77)92496-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  46 in total

Review 1.  Clinical significance of prostacyclin and thromboxane in cancer of the female breast and genital tract.

Authors:  S Nigam; A Zakrzewicz; S Eskafi; A Roscher
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 2.  Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.

Authors:  Jocelyn Reader; Dawn Holt; Amy Fulton
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

3.  Prognostic significance of plasma prostaglandin E concentration in patients with head and neck cancer.

Authors:  I Klapan; V Katić; F Culo; V Cuk
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients.

Authors:  Tariq Moatter; Muniba Aban; Waseem Iqbal; Shahid Pervez
Journal:  Pathol Oncol Res       Date:  2014-05-03       Impact factor: 3.201

5.  Malignant hypercalcaemia.

Authors:  J C Stevenson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-17

6.  Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers [proceedings].

Authors:  A Bennett; D A Berstock; B Raja; I F Stamford
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

7.  COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients.

Authors:  Bar Chikman; Sergey Vasyanovich; Ron Lavy; Liliana Habler; Gleb Tolstov; Andronik Kapiev; Ariel Halevy; Judith Sandbank
Journal:  Med Oncol       Date:  2014-05-10       Impact factor: 3.064

8.  A high level of prostaglandin E2 (PGE2) in the portal vein suppresses liver-associated immunity and promotes liver metastases.

Authors:  K Okuno; H Jinnai; Y S Lee; K Nakamura; T Hirohata; H Shigeoka; M Yasutomi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  Inhibition by indomethacin of spontaneous mammary tumorigenesis in SHN mice.

Authors:  H Nagasawa; T Naito
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

10.  Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate.

Authors:  A Bennett; J D Gaffen; P B Melhuish; I F Stamford
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.